A Study of ASP3082 in Adults With Advanced Solid Tumors
for Solid Tumor
24 locations incl. Duarte
Sponsor: Astellas Pharma Inc
Sex: All·Age: 18+
Code: NCT05382559·Phase 1·Recruiting·Listed May 2022
NEXT/Virginia Cancer Specialists
Clinical research site in Fairfax, Virginia · 8613 LEE HWY # 200N, FAIRFAX, VA 22031-2171 · (703) 280-5390 · Website
Part of US Oncology
As of July 2026, 8 paid clinical trials are recruiting at NEXT/Virginia Cancer Specialists in Fairfax, Virginia. Active studies at this site cover conditions such as Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors and CNS Metastases. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at NEXT/Virginia Cancer Specialists (8)
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for HER2 Mutation-Related Tumors
29 locations incl. La Jolla
Sponsor: Iambic Therapeutics, Inc
Sex: All·Age: 18+
Code: NCT06253871·Phase 1·Recruiting·Listed Feb 2024
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for Plasma Cell Myeloma Refractory
34 locations incl. Phoenix
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06356571·Phase 2·Recruiting·Listed Apr 2024
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
for Endometrial Cancer
12 locations incl. Little Rock
Sponsor: Whitehawk Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07444814·Phase 1·Recruiting·Listed Mar 2026
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
for Locally Advanced Solid Tumor
19 locations incl. Orange
Sponsor: Nuvalent Inc.
Sex: All·Age: 12+
Code: NCT05118789·Phase 1, Phase 2·Recruiting·Listed Nov 2021
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
for Advanced Solid Tumor
1 location in Fairfax
Sponsor: Blueprint Medicines Corporation
Sex: All·Age: 18+
Code: NCT07629960·Phase 1, Phase 2·Recruiting·Listed Jun 5, 2026
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
for Advanced Solid Tumors
8 locations incl. Palo Alto
Sponsor: FoRx Therapeutics AG
Sex: All·Age: 18+
Code: NCT07356453·Phase 1·Recruiting·Listed Jan 2026
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
for Ovarian Cancer
2 locations incl. Dallas
Sponsor: Hefei TG ImmunoPharma Co., Ltd.
Sex: All·Age: 18+
Code: NCT05746897·Phase 1·Recruiting·Listed Feb 2023
More research sites in Fairfax
- NEXT Virginia (72 trials)
- Virginia Cancer Specialists (65 trials)
- Inova Schar Cancer Institute (57 trials)
- NEXT Oncology Virginia (29 trials)
- NEXT Oncology (25 trials)
- Virginia Cancer Specialists, PC (17 trials)
- Inova Fair Oaks Hospital (14 trials)
- Re:Cognition Health (7 trials)
- Inova Schar Cancer (6 trials)
- Inova Fairfax Hospital (5 trials)
Explore more
Paid clinical trials in Fairfax, VA · Virginia clinical trials